AB
VINC

Amalgamated Bank’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Amalgamated Bank’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-134
Closed -$11K – 3238
2022
Q1 		$11K Buy
+134
New +$16.6K ﹤0.01% 2950

Other funds holding VINC

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SRC
Sage Rhino Capital Menlo Park, California $535M AUM 24.07% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Amalgamated Bank's VINC Position: Q2 2022 in Review

Amalgamated Bank sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2022, closing a stake of 134 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in VINC in Q1 2022 and held it in 1 quarter. The position peaked at $11K in Q1 2022. 51 funds tracked by Wall St. Rank hold VINC as of Q2 2022.

  • Amalgamated Bank reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 134 Vincerx Pharma, Inc. Common Stock shares in Q2 2022, an estimated $11K.
  • Amalgamated Bank first reported a position in Vincerx Pharma, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Vincerx Pharma, Inc. Common Stock position peaked at $11K in Q1 2022.
  • 51 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.